Anyone already balding before their first testosterone cycle - did Finasteride/Dutasteride or RU58841 actually save your hair?
    7/31/2026

    From the encyclopedia
    Finasteride →

    Prescription tablet (1 mg) that slowed hair loss versus placebo in two-year trials. Labels warn of sexual side effects that have continued after stopping, and of depression and suicidal thoughts; not for use in pregnancy.

    Dutasteride →

    A stronger DHT blocker than finasteride, approved for hair loss only in South Korea and Japan and off-label elsewhere, with the same class of side effects and a much longer washout.

    RU58841 →

    An unapproved research chemical with no published human trial for hair loss. A small 2026 study found it reaches the blood after one scalp application.

    At a glance
    In this question or advice post, the primary subjects mentioned are the tone is 😐 neutral with stopped the loss, still stable results.

    Other terms

    The conversation discusses hair loss treatments, specifically using finasteride, dutasteride, RU58841, and minoxidil. Users share experiences on maintaining or regrowing hair during testosterone cycles.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.

      research Андрогенетическая алопеция: патогенетические механизмы и подходы к лечению

      January 2013 in “Российский журнал кожных и венерических болезней”
      This article reviews the pathophysiology and limited effectiveness of current treatments for androgenic alopecia, including finasteride, minoxidil, botulinum toxin A, and platelet-rich plasma, and highlights the need for new therapeutic approaches; it reports no new clinical findings.

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.